Holen Sie sich die Stockscreener-App
1.41
0.00%
0.00
Schlusskurs vom Vortag:
$1.41
Offen:
$1.4
24-Stunden-Volumen:
1.62M
Relative Volume:
0.38
Marktkapitalisierung:
$461.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.08M
KGV:
-5.2222
EPS:
-0.27
Netto-Cashflow:
$-72.53M
1W Leistung:
+6.02%
1M Leistung:
-26.18%
6M Leistung:
+36.89%
1J Leistung:
+100.65%
1-Tages-Spanne:
$1.3901
$1.47
1-Wochen-Bereich:
$1.31
$1.475
52-Wochen-Spanne:
$0.515
$1.96
Ocugen Inc Stock (OCGN) Company Profile
Firmenname
Ocugen Inc
Sektor
Branche
Telefon
484-328-4701
Adresse
11 GREAT VALLEY PARKWAY, MALVERN, PA
Compare OCGN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.41 | 461.52M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-15 | Eingeleitet | Maxim Group | Buy |
| 2023-03-01 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Eingeleitet | Mizuho | Buy |
| 2022-06-15 | Fortgesetzt | ROTH Capital | Buy |
| 2022-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-06-11 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Alle ansehen
Ocugen Inc Aktie (OCGN) Neueste Nachrichten
How cyclical is Ocugen Inc. (2H51) stock compared to rivalsWeekly Trade Review & Fast Gain Stock Trading Tips - mfd.ru
Aug EndMonth: Is Ocugen Inc a momentum stockJuly 2025 Market Mood & Risk Controlled Stock Alerts - baoquankhu1.vn
Highs Report: Is Ocugen Inc a cyclical or defensive stock2025 Retail Activity & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
What The Latest Developments Mean For Ocugen’s Changing Valuation Story - Yahoo Finance
Ocugen foresees gene-agnostic therapies advancing blindness treatment - Traders Union
Ocugen appoints Rita Johnson-Greene as chief financial officer - Pennsylvania Business Report -
Ocugen Bolsters Leadership Ahead of Critical Regulatory Milestone - AD HOC NEWS
Ocugen appoints Rita Johnson-Greene as new CFO By Investing.com - Investing.com South Africa
Ocugen appoints Rita Johnson-Greene as chief financial officer By Investing.com - Investing.com Canada
Ocugen Appoints Rita Johnson-Greene as New Chief Financial Officer - TipRanks
Ocugen (OCGN) Appoints New CFO, Shares Rise - GuruFocus
Ocugen (OCGN) Appoints New CFO to Strengthen Leadership Team - GuruFocus
Ocugen, Inc. Appoints New Chief Financial Officer - TradingView
Ocugen Names Rita Johnson-Greene as CFO - marketscreener.com
Ocugen appoints Rita Johnson-Greene as new CFO - Investing.com
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer - citybiz
Ocugen, Inc. Appoints Rita Johnson-Greene as Chief Financial Officer - Quiver Quantitative
Ocugen Appoints Rita Johnson-Greene To Chief Financial Officer - TradingView
Cell and gene therapy exec Rita Johnson-Greene joins Ocugen as CFO - Stock Titan
Ocugen grants CEO new performance-based equity award - MSN
Wall Street Recap: Can Ocugen Inc be recession proof2025 Price Action Summary & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Breakout Move: Will Ocugen Inc stock recover after earningsJuly 2025 Levels & Real-Time Market Trend Scan - baoquankhu1.vn
Ocugen’s Gene Therapy Progress and Funding Extend Runway - AD HOC NEWS
Ocugen Shares Stabilize Following Recent Equity Offering - AD HOC NEWS
Trade Report: Can Ocugen Inc be recession proofWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates - MSN
Ocugen Doses First Patient in Pivotal Trial for Stargardt Gene Therapy - MSN
Ocugen prices $22.5M common stock offering at $1.50 per share - MSN
What are analysts price targets for Ocugen IncJuly 2025 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Valuation Update: Can Belite Bio Inc Depositary Receipt deliver alphaWeekly Market Outlook & Smart Allocation Stock Tips - baoquankhu1.vn
RSI Check: Can Ocugen Inc weather a recessionWeekly Trading Summary & Community Consensus Trade Alerts - baoquankhu1.vn
Ocugen’s Gene Therapy Candidate Shows Promise in Early-Stight Loss Trial - AD HOC NEWS
Ocugen’s Stargardt Gene Therapy OCU410ST Provides +6-Letter Gain in BCVA-Evaluable Patients in Phase 1 Trial - NeurologyLive
Ocugen’s Gene Therapy OCU410ST Continues to Show Efficacy in Phase 1 Stargardt Disease Trial - CGTLive®
Ocugen stock surges 75% year to date: What's in store for 2026? - MSN
Ocugen Raises $20.9M to Extend Cash Runway Into Late 2026 - MyChesCo
Macro Review: Is Ocugen Inc forming a double bottom2025 Volatility Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Ocugen Stock: A Turnaround Fueled by Promising Trial Data - AD HOC NEWS
Ocugen’s Clinical Pipeline Takes Center Stage Following Capital Raise - AD HOC NEWS
How The Narrative Around Ocugen (OCGN) Is Shifting After The Latest Price Target Change - Yahoo Finance
Ocugen Secures Financial Runway Through Strategic Capital Raise - AD HOC NEWS
Ocugen Secures Funding to Advance Gene Therapy Pipeline - AD HOC NEWS
Ocugen Secures Funding at a Short-Term Cost to Shareholders - AD HOC NEWS
Ocugen Shares Defy Dilution Fears on Strong Clinical Data - AD HOC NEWS
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock - Sahm
Ocugen closes $22.5 million registered direct offering By Investing.com - Investing.com South Africa
Ocugen Secures Financial Runway Through 2026 - AD HOC NEWS
How Fresh Capital And Positive OCU410 Data At Ocugen (OCGN) Has Changed Its Investment Story - Yahoo Finance
Ocugen strengthens balance sheet with new equity financing - TipRanks
Ocugen, Inc. Closes $22.5 Million Stock Offering - TradingView
Ocugen closes $22.5 million registered direct offering - Investing.com
Finanzdaten der Ocugen Inc-Aktie (OCGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):